<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="69130">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02205866</url>
  </required_header>
  <id_info>
    <org_study_id>1403-VLC-012-JB</org_study_id>
    <nct_id>NCT02205866</nct_id>
  </id_info>
  <brief_title>Incidence of Non Receptive Endometrium in Obese Women</brief_title>
  <official_title>Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Valenciano de Infertilidad, IVI VALENCIA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the incidence of Non Receptive endometrium in obese infertile women
      compared to infertile normal weight women using Endometrial Receptivity Array (ERA) test,
      containing 238 genes, identifying the receptivity status of an endometrial sample and
      diagnosing the patient's Window of Implantation, regardless of the histological appearance
      of the sample. An endometrial biopsy is collected from the uterine fundus, either in a
      natural cycle or in a hormonal replacement therapy (HRT) cycle and the test is performed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non Receptive Endometrium</measure>
    <time_frame>25 days</time_frame>
    <description>To evaluate the incidence of Not Receptive endometrium in obese infertile women compared to infertile normal weight women using an adequate sample size.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Distribution of fat and risk factors</measure>
    <time_frame>4 months</time_frame>
    <description>Carry out a subanalysis concerning the distribution of central and peripheric fat and risk factors of metabolic syndrome including: Age (years); Height (m); Weight (kg) ; BMI (kg/m2); Waist (cm) ; Hip (cm); Index waist-hip ratio (WHR) waist (cm) / hip (cm); Blood pressure; insulinemia Fasting blood glucose (mmol / L); PTG ( tolerance oral glucose ) (mmol / L), Total cholesterol and fractions; Triglycerides Microalbuminuria; bA1C, HC-reactive protein.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Look for specific endometrial gene patterns.</measure>
    <time_frame>25 days</time_frame>
    <description>Find patterns of expression of specific genes in endometrial obese women: we will by analyzing the expression of 238 genes obtained after endometrial endometrial biopsy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non Obese patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Obese patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endometrial Receptivity Array analysis of endometrial biopsy</intervention_name>
    <description>A biopsy of endometrium is peformed and Endometrial Receptivity Array analysis is carried out, as well as analysis of fat distribution and risk factors of Metabolic Syndrome.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infertile women: &gt; 1 year of regular unprotected intercourse without evidence of
             pregnancy.

          -  Normal uterus by 2D/3D ultrasound scan and/or hysteroscopy

          -  No endometriosis

          -  Presence of both ovaries

          -  &lt; 45 years old (in ovum donation, outcome parameters are not affected until this age
             in all the current published studies).

        Exclusion Criteria:

          -  Hydrosalpinx

          -  Stage 3-4 endometriosis diagnosed with ultrasound, laparoscopy/ laparotomy.

          -  Implantation failure (≥ 4 pre-embryos of good quality transferred without pregnancy)

          -  Recurrent pregnancy loss (≥ 2 pregnancies biochemical / clinical)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Bellver, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Valencia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sergio Cabanillas, MD</last_name>
    <phone>+34963050900</phone>
    <email>sergio.cabanillas@ivi.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stamford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305-5101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Lathi, MDPhD</last_name>
      <email>rlathi@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Cabanillas, MD</last_name>
      <phone>963050900</phone>
      <email>sergio.cabanillas@ivi.es</email>
    </contact>
    <investigator>
      <last_name>Jose Bellver, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sergio Cabanillas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Simon, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Bellver, MDPhD</last_name>
      <phone>+34963050900</phone>
      <email>jose.bellver@ivi.es</email>
    </contact>
    <investigator>
      <last_name>Jose Bellver, MDPhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 6, 2016</lastchanged_date>
  <firstreceived_date>July 25, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Valenciano de Infertilidad, IVI VALENCIA</investigator_affiliation>
    <investigator_full_name>Jose Bellver</investigator_full_name>
    <investigator_title>Dr. Jose Bellver</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
